Vuzix Corporation (NASDAQ:VUZI) (FRA:V7XN) has announced a follow-up order of additional Vuzix Blade Smart Glasses from Medacta International, one of the world’s largest providers of orthopedic products, to support its NextAR augmented reality surgical platform.
Having used the Vuzix Blade to complete the first smart glasses-based total knee replacement in the US in 2020, Medacta is now using the glasses to leverage AR in shoulder, hip and spine surgeries.
The NextAR platform employs a preoperative scan, using proprietary algorithms to create a personalized biomechanical model for each replacement. Surgeons equipped with Vuzix Blade Smart Glasses can then access biomechanical visualizations during the procedure in real time, without having to glance away at a computer screen.
READ: Vuzix says Verizon's video conferencing platform, BlueJeans now supported by M4 smart glasses
This system gives surgeons control over every detail of a surgery and eliminates the need for bulky robotic arms or dedicated equipment operators in the operating room, which also reduces costs.
"There's no secret about the connection between comfort and adoption of AR technology, and ongoing orders like the ones we're receiving for the Blade are proof of it," Vuzix CEO Paul Travers said in a statement.
"Vuzix Smart Glasses are lightweight, comfortable and completely wireless, which means surgeons have complete freedom of movement and can wear them for extended operations. We're proud to provide the hardware backbone for Medacta's NextAR platform as it continues to branch into new applications and are looking forward to their certification testing with our M400 and M4000 Smart Glasses."
Contact Andrew Kessel at andrew.kessel@proactiveinvestors.com
Follow him on Twitter @andrew_kessel